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Pancreatic hamartomas occur extremely rarely. They may appear as sol-
id masses or cystic forms and should be regarded as malformations rather
than neoplasms [1]. Due to absence of characteristic differential features
they may be clinically and radiologically mistaken for a malignancy [2].
Misinterpretation of hamartoma as a true neoplasm may result in unnec-
essarily aggressive surgery. The authors herein present a case report of
solid pancreatic hamartoma and demonstrate its characteristics along
with a review of the literature and discuss the problem of potential
overtreatment of these patients.
A 69-year-old male patient was presented with a hypoechogenic,
asymptomatic pancreatic body mass, incidentally revealed by ultra-
sonography. The patient gave no medical history of either chronic pan-
creatitis or other diseases of the pancreas. Pancreatitis and neoplasm (CEA,
CA 19-9) markers were within the normal range; pancreatic exocrine and
endocrine function was sufficient. Further endosonography scans revealed
a 28 mm × 22 mm hypoechogenic tumour-like lesion within the body of
the pancreas (Figure 1). Computed tomography scans confirmed a solid
tumor with ill-demarcated margin (Figure 2). The patient was qualified for
surgical treatment. Intraoperatively, the oval, pancreatic body mass of firm
consistency was confirmed. Central pancreatic resection with Roux-en-Y
pancreaticojejunostomy to the distal pancreatic remnant was performed.
The postoperative period was complicated by leakage from the pancre-
atojejunostomy. Reoperation with re-suturing of the anastomosis was
applied. The remaining postoperative time was uneventful. So far, the
patient has been followed up for 55 months and has remained disease-
free.
Macroscopically, a firm, solid, whitish, well-circumscribed, encapsulat-
ed mass measuring 3 cm in maximum diameter was confirmed. Histo-
logically, the tumour was almost entirely composed of disorderly arranged,
well-differentiated endocrine and exocrine pancreatic tissue (Figure 3).
The spindle morphology of a small quantity of stroma cells and cystical-
ly dilated pancreatic ducts, filled with pancreatic juice, were observed
(Figure 4). The tumour was surrounded by adjacent normal pancreatic
parenchyma without significant fibrosis or features of chronic inflamma-
tion. Insulin, glucagon, chromogranin, somatostatin, amylase, CD34, CD117,
S-100 and desmin immunostainings confirmed colocalization of the typi-
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chemical analysis of CD34 and CD117 showed
a negative reaction in elongated stoma tumour
cells. Therefore, the diagnosis of pancreatic hamar-
toma was established. 
Hamartomas of the pancreas are rarely report-
ed, since only a few cases have been described in
the literature. Clinicopathological features of all not-
ed cases are summarized in Table I [2-10]. Some
authors have observed that this kind of lesion
includes spindle-shaped cells which are immunore-
active for CD34 and CD117 [9]. The descriptive term
of these tumours as cellular hamartomas resem-
bling gastrointestinal stromal tumours was sug-
gested. In our case, pathological changes in the cel-
lular shape of stroma cells were observed, although
immunohistochemical tests for CD 34 and CD117
were  non-contributory,  which  excludes  such
a pathological characterization.
The histogenetic concept of hamartomas is
enigmatic. Hamartomas of the pancreas were
thought to coexist with chronic pancreatitis. On
the other hand, Pauser et al. excluded such cas-
es from this group. In the authors’ opinion, the
term  of  hamartoma  should  be  reserved  for
asymptomatic  patients.  The  hypothesis  that
inflammation is one of the factors that induce
hamartoma development is not valid, since chron-
ic pancreatitis may just mimic hamartoma lesions
lacking acinar cells. 
The natural course of hamartoma is not charac-
teristic, as in our described case. Routine laborato-
ry tests and imaging studies are non-contributory
in establishment of the final diagnosis. Needle biop-
sy is suggested to be feasible in differential diag-
nosis. However, false negative results may occur
frequently, and it may be associated with tumour
cells seeding in malignancy. Thus, in the authors’
opinion, patients with solitary incidentaloma such
as hamartoma of the pancreas should not under-
go routine pancreatic tumour biopsy.
Currently, preoperative differentiation between
hamartomas or other benign tumours and malig-
nancies is very difficult, if not in many cases impos-
sible. As a consequence, it raises a question about
treatment of patients with incidentally diagnosed
solitary pancreatic tumour of unknown character.
In view of the fact that pre-malignant and malig-
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tumour within the body of the pancreas
F Fi ig gu ur re e   3 3. .   Exocrine part of the pancreas with islets
and adipose tissue. HE, 120×
F Fi ig gu ur re e   4 4. .   Dilated pancreatic ducts. HE, 120×
Asymptomatic solid pancreatic hamartoma
Arch Med Sci 6, December / 2011 10831084 Arch Med Sci 6, December / 2011
nant histology of pancreatic asymptomatic inci-
dentalomas is far more frequent, still surgical exci-
sion  should  be  the  treatment  of  choice,  even
though aggressive surgery may be overtreatment
in patients among whom postoperative histopatho-
logical examination revealed hamartoma or other
benign tumour.
In  conclusion,  pancreatic  hamartoma  is  an
extremely rare medical problem. Misinterpretation
of asymptomatic hamartomas as a true neoplasms
may result in unnecessarily aggressive surgery. Nev-
ertheless, preoperative diagnostic difficulties may
be finally resolved only with histopathological
examination of the postoperative specimen. 
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Anthony et al. [3] 46 years M Head 1.6 Pancreaticoduodenectomy
Anthony et al. [3] 35 years M Tail Multiple Local resection
Anthony et al. [3] 58 years M Head 1.0 Autopsy
Burt et al. [4] 34 weeks F Diffuse 11.5 Total pancreatectomy
Flaherty et al. [5] 20 months F Head 9.0 Local resection
Izbicki et al. [6] 25 years M Head 10.6 Pancreaticoduodenectomy
Wu et al. [7] 39 years M Head 8.0 Pancreaticoduodenectomy
McFaul et al. [8] 29 years M Head 1.0 Pancreaticoduodenectomy
McFaul et al. [8] 62 years M Head 3.5 Pancreaticoduodenectomy
Pauser et al. [2] 36 years F Head 7.0 Pancreaticoduodenectomy
Pauser et al. [2] 55 years F Neck 3.0 Distal pancreatectomy
Pauser et al. [9] 51 years M Tail 3.0 Local resection
Pauser et al. [9] 54 years F Body 2.0 Distal pancreatectomy
Nagata et al. [10] 58 years F Body 1.9 Distal pancreatectomy
T Ta ab bl le e   I I. . Characteristics of pancreatic hamartomas reported in the literature